Patient Attitudes Toward the Use of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium difficile Infection
Author(s) -
Jonathan S. Zipursky,
Tivon Sidorsky,
Christine Freedman,
Misha N Sidorsky,
Kathryn B. Kirkland
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis809
Subject(s) - clostridium difficile , fecal bacteriotherapy , medicine , clostridium infections , transplantation , feces , clostridiaceae , intensive care medicine , microbiology and biotechnology , immunology , surgery , antibiotics , biology , toxin
Fecal microbiota transplantation (FMT), a safe, effective alternative therapy for recurrent Clostridium difficile infection (CDI), is infrequently used, in part because of an assumption that patients are unwilling to consider FMT because of its unappealing nature.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom